Related Experiment Video
Updated: Aug 21, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
Hsp90: the vulnerable chaperone
Gabriela Chiosis1, Maria Vilenchik, Joungnam Kim
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. chiosisg@mskcc.org <chiosisg@mskcc.org>
Abstract:
The molecular chaperone Hsp90 has emerged as an important target in cancer treatment because of its roles in maintaining transformation and regulating the function of proteins involved in apoptotic, survival and growth pathways. Many Hsp90 inhibitors function by binding to the N-terminal ATP pocket, but the chaperone has many other vulnerable points. Agents that interact with its C-terminus or modify its post-translational status represent additional ways of interfering with chaperone activity. This review will discuss several emerging classes of Hsp90 inhibitors and their modes of action.
Insights
Heat shock protein 90 (Hsp90) is a cancer target. New inhibitors target Hsp90's C-terminus or post-translational modifications, offering novel therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Heat shock protein 90 (Hsp90) is a crucial molecular chaperone involved in cancer progression.
- Hsp90 regulates key proteins in apoptotic, survival, and growth pathways, making it a significant cancer target.
- Current Hsp90 inhibitors primarily target the N-terminal ATP pocket.
Purpose of the Study:
- To review emerging classes of Hsp90 inhibitors.
- To discuss novel modes of action for interfering with Hsp90 chaperone activity.
- To highlight alternative strategies beyond N-terminal ATP pocket inhibition.
Main Methods:
- Literature review of emerging Hsp90 inhibitor classes.
- Analysis of Hsp90 inhibitor mechanisms of action.
- Discussion of agents targeting Hsp90's C-terminus and post-translational modifications.
Main Results:
- Several emerging classes of Hsp90 inhibitors have been identified.
- Inhibitors targeting the C-terminus and post-translational modifications represent viable alternative strategies.
- These novel approaches offer new ways to disrupt Hsp90 chaperone activity.
Conclusions:
- Targeting Hsp90 remains a promising strategy in cancer therapy.
- Exploring alternative binding sites and modification strategies expands the therapeutic potential of Hsp90 inhibitors.
- Emerging Hsp90 inhibitors offer novel avenues for cancer treatment.
More Related Videos
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
The...
Bacterial Protein Maturation
Export of Misfolded Proteins out of the ER
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

